1. SAT0099 Polypharmacy is associated with an increased risk of adverse outcomes in patients with rheumatoid arthritis. (15th June 2017) Authors: Vallejo, AD Amarilla; Rutherford, A; Filkova, M; Molokhia, M; Nikiphorou, E; Norton, S; Hyrich, K; Galloway, J Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 806 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗